Ravindra Kolhe is a Professor and Leon Henri Charbonnier
Endowed Chair of Pathology at the Medical College of Georgia at Augusta
University. He is also the inaugural Associate Dean for Translation Research at
the Medical College of Georgia. He serves as the Associate Cancer Center
Director for Genomics at the Georgia Cancer Center. Currently, he leads an
NCI-designated translational pathology laboratory for MATCH testing, which is
focused on comprehensive genomic testing in oncology. He co-founded a
consortium (SEQUOIA) of over 40+ clinical laboratories across the globe for the
democratization of NGS testing in oncology and successfully helped multiple
labs bring NGS testing in-house. He has led several studies focused on adapting
and validating newer technologies (NGS, RNA-seq, OGM, etc.) in CLIA
laboratories by establishing PLA, Z-codes, GAP filing, and reimbursement. He
has an h-Index of 28, and his papers have been cited more than 2400 times
(Scopus, 1 November 2023).
Short Biography
Ravindra Kolhe is a Professor and Leon Henri Charbonnier
Endowed Chair of Pathology at the Medical College of Georgia at Augusta
University. He is also the inaugural Associate Dean for Translation Research at
the Medical College of Georgia. He serves as the Associate Cancer Center
Director for Genomics at the Georgia Cancer Center. Currently, he leads an
NCI-designated translational pathology laboratory for MATCH testing, which is
focused on comprehensive genomic testing in oncology. He co-founded a
consortium (SEQUOIA) of over 40+ clinical laboratories across the globe for the
democratization of NGS testing in oncology and successfully helped multiple
labs bring NGS testing in-house. He has led several studies focused on adapting
and validating newer technologies (NGS, RNA-seq, OGM, etc.) in CLIA
laboratories by establishing PLA, Z-codes, GAP filing, and reimbursement. He
has an h-Index of 28, and his papers have been cited more than 2400 times
(Scopus, 1 November 2023).